RESUMEN
Climate change is expected to increase the number of heat wave events, leading to prolonged exposures to severe heat stress (HS) and the corresponding adverse effects on dairy cattle productivity. Modelling dairy cattle productivity under HS conditions is complicated because it requires comprehending the complexity, non-linearity, dynamicity, and delays in animal response. In this paper, we applied the System Dynamics methodology to understand the dynamics of animal response and system delays of observed milk yield (MY) in dairy cows under HS. Data on MY and temperature-humidity index were collected from a dairy cattle farm. Model development involved: (i) articulation of the problem, identification of the feedback mechanisms, and development of the dynamic hypothesis through a causal loop diagram; (ii) formulation of the quantitative model through a stock-and-flow structure; (iii) calibration of the model parameters; and (iv) analysis of results for individual cows. The model was successively evaluated with 20 cows in the case study farm, and the relevant parameters of their HS response were quantified with calibration. According to the evaluation of the results, the proposed model structure was able to capture the effect of HS for 11 cows with high accuracy with mean absolute percent error <5%, concordance correlation coefficient >0.6, and R2 > 0.6, except for two cows (ID #13 and #20) with R2 less than 0.6, implying that the rest of the nine animals do not exhibit heat-sensitive behaviour for the defined parameter space. The presented HS model considered non-linear feedback mechanisms as an attempt to help farmers and decision makers quantify the animal response to HS, predict MY under HS conditions, and distinguish the heat-sensitive cows from heat-tolerant cows at the farm level.
Asunto(s)
Enfermedades de los Bovinos , Trastornos de Estrés por Calor , Femenino , Bovinos , Animales , Lactancia/fisiología , Calor , Leche/química , Respuesta al Choque Térmico/fisiología , Temperatura , Trastornos de Estrés por Calor/veterinaria , Enfermedades de los Bovinos/etiologíaRESUMEN
Systems perspectives and system dynamics have been widely used in decision-making for agricultural problems. However, their use in dairy farm management remains limited. This work demonstrates the use of systems approaches and feedback thinking in modelling for dairy farm management. The application of feedback thinking was illustrated with causal loop and stock-and-flow diagrams to disentangle the complexity of the relationship among farm elements. The study aimed to identify the dynamic processes of an intensive dairy farm by mapping the animal stocks (e.g., heifers, lactating cows, dry cows) with the final objective of anticipating the expected milk deliveries over a long time period. The project was conducted for a reference dairy farm that was intensively managed with a herd size of >2â¯500 cattle heads, which provided monthly farm records from Jan 2016 to Dec 2019. Model development steps included: (i) problem articulation with farm interviews and data analysis; (ii) the development of a dynamic hypothesis and a causal loop diagram; (iii) the development of a stock-and-flow cattle model describing ageing chains of heifers and cows and subsequent calibration of the model parameters; (iv) the evaluation of the model based on lactating cows and milk deliveries against farm historical records; and (v) the analysis of the model results. The model characterized the farm dynamics using three main feedback loops: one balancing loop of culling and two reinforcing loops of heifers' replacement and cows' pregnancy, pushing milk delivery. The model reproduced the historical oscillation patterns of lactating cows and milk deliveries with high accuracy (root mean square percentage error of 2.8 and 5.2% for the number of lactating cows and milk deliveries, respectively). The model was shown to be valid for its purpose, and applications of this model in dairy farm management can support decision-making practices for herd composition and milk delivery targets.
Asunto(s)
Industria Lechera , Lactancia , Embarazo , Bovinos , Animales , Femenino , Granjas , Retroalimentación , Industria Lechera/métodos , LecheRESUMEN
Nicotine and cocaine- and amphetamine-regulated transcripts (CART) have several overlapping functions, such as the regulation of reward, feeding behavior, stress response, and anxiety. Previous studies showed that nicotine regulates CART expression in various brain regions. However, the molecular mechanisms underlying this regulation are not known. This study investigated the regulatory effect of nicotine on promoter activity of the CART gene in PC12 cells, which were differentiated into a neuronal phenotype by nerve growth factor (NGF) treatment. Two vectors containing reporter genes (Gaussia luciferase or mCherry) and the 1,140-bp upstream of the transcriptional start site of the mouse CART gene are used to analyze the CART promoter activity. Transient transfection of PC12 cells with either vector displayed strong promoter activity in both undifferentiated and differentiated PC12 cells. CART promoter activity in the PC12 cell line is increased by forskolin or NGF treatment. In differentiated PC12 cells, exposure to 50 nM nicotine for 6 h increased CART promoter activity. However, treatment with higher nicotine doses for 6 h and treatment with all nicotine doses for 24 h showed no effect. A nicotine concentration of 50 nM is comparable to brain nicotine levels experienced by chronic smokers over long periods of time. Taken together, these data indicate that nicotine may exert some of its actions through the regulation of CART transcription in the brain.
Asunto(s)
Factor de Crecimiento Nervioso/farmacología , Proteínas del Tejido Nervioso/efectos de los fármacos , Nicotina/farmacología , Regiones Promotoras Genéticas/efectos de los fármacos , Animales , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , Línea Celular Tumoral , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/genética , Genes Reporteros/efectos de los fármacos , Genes Reporteros/genética , Ratones , Proteínas del Tejido Nervioso/genética , Neuronas/efectos de los fármacos , Células PC12 , Regiones Promotoras Genéticas/genética , Ratas , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Transcripción Genética/efectos de los fármacos , Transcripción Genética/genética , Transfección/métodosRESUMEN
Donkey milk and donkey milk kefir exhibit antiproliferative, antimutagenic and antibacterial effects. We investigated the effects of donkey milk and donkey milk kefir on oxidative stress, apoptosis and proliferation in Ehrlich ascites carcinoma (EAC) in mice. Thirty-four adult male Swiss albino mice were divided into four groups as follows: group 1, administered 0.5 ml water; group 2, administered 0.5 ml water + EAC cells; group 3, administered 0.5 ml donkey milk + EAC cells; group 4, administered 0.5 ml donkey milk kefir + EAC cells. We introduced 2.5 x 106 EAC cells into each animal by subcutaneous injection. Tap water, donkey milk and donkey milk kefir were administered by gavage for 10 days. Animals were sacrificed on day 11. After measuring the short and long diameters of the tumors, tissues were processed for histology. To determine oxidative stress, cell death and proliferation iNOS and eNOS, active caspase-3 and proliferating cell nuclear antigen were assessed using immunohistochemistry. A TUNEL assay also was used to detect apoptosis. Tumor volume decreased in the donkey milk kefir group compared to the control and donkey milk groups. Tumor volume increased in the donkey milk group compared to the control group. Proliferating cell nuclear antigen levels were higher in the donkey milk kefir group compared to the control and donkey milk groups. The number of apoptotic cells was less in the donkey milk group, compared to the control, whereas it was highest in the donkey milk kefir group. Donkey milk administration increased eNOS levels and decreased iNOS levels, compared to the control group. In the donkey milk kefir group, iNOS levels were significantly lower than those of the control and donkey milk groups, while eNOS levels were similar to the control group. Donkey milk kefir induced apoptosis, suppressed proliferation and decreased co-expression of iNOS and eNOS. Donkey milk promoted development of the tumors. Therefore, donkey milk kefir appears to be more beneficial for treating breast cancer than donkey milk.
Asunto(s)
Ascitis/metabolismo , Productos Lácteos Cultivados , Kéfir , Óxido Nítrico Sintasa de Tipo II/metabolismo , Animales , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Regulación hacia Abajo , Equidae , Masculino , Ratones , Leche/metabolismo , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiologíaRESUMEN
The enzyme dipeptidyl peptidase-IV (DPP-4) inactivates the incretin hormone glucagon-like peptide-1 (GLP-1). Because GLP-1 has therapeutic effects in patients with type 2 diabetes, but its potential is limited by a short half-life, DPP-4 inhibition is a promising approach to diabetes treatment. This study examined acute (single dose) and chronic (once-a-day dosing for 21 days) effects of the DPP-4 inhibitor vildagliptin (0.03-10 mg/kg) on plasma DPP-4 activity, intact GLP-1, glucose, and insulin after an oral glucose load in insulin-resistant Zucker fatty rats and acute effects in mildly insulin-resistant high-fat-fed normal rats. A single oral dose of vildagliptin in Zucker rats produced a rapid and dose-related inhibition of DPP-4: the minimum effective dose (MED) was 0.3 mg/kg. Glucose-induced increases of intact GLP-1 were greatly but similarly enhanced by vildagliptin at doses > or =0.3 mg/kg. Postload glucose excursions decreased, and the insulinogenic index (Deltainsulin/Deltaglucose at 10 min) increased, with an MED of 0.3 mg/kg and a maximally effective dose of 3 mg/kg. The effects of vildagliptin after chronic treatment were nearly identical to those of acute administration, and vildagliptin had no effect on body weight. In fat-fed normal rats, vildagliptin (3 mg/kg) also decreased postload glucose excursions and increased the insulinogenic index, but these effects were smaller than those in Zucker rats. Thus, vildagliptin is an orally effective incretin enhancer with antihyperglycemic activity in insulin-resistant rats and exhibits no tachyphylaxis. GLP-1-mediated augmentation of glucose-induced insulin release seems to make the major contribution to the antidiabetic properties of vildagliptin.
Asunto(s)
Adamantano/análogos & derivados , Resistencia a la Insulina/fisiología , Adamantano/farmacología , Animales , Área Bajo la Curva , Glucemia/metabolismo , Grasas de la Dieta/efectos adversos , Dipeptidil Peptidasa 4/sangre , Relación Dosis-Respuesta a Droga , Péptido 1 Similar al Glucagón/sangre , Intolerancia a la Glucosa/fisiopatología , Glucosa Oxidasa , Prueba de Tolerancia a la Glucosa , Resistencia a la Insulina/genética , Masculino , Nitrilos , Pirrolidinas , Ratas , Ratas Zucker , Taquifilaxis/fisiología , Factores de Tiempo , Vildagliptina , Aumento de Peso/efectos de los fármacosAsunto(s)
Anestesia General , Máscaras Laríngeas , Procedimientos Quirúrgicos Oftalmológicos , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Intubación Intratraqueal , MasculinoRESUMEN
PURPOSE: Topical anesthesia is increasingly being used for cataract surgery. However, it is believed that topical anesthesia causes an increased risk of intraoperative complications from unrestricted eye movement and insufficient pain control and more need for sedation. It is difficult to compare pain and anxiety experienced by individual patients; therefore, the authors used the method of patient-controlled sedation to determine whether there is a difference in sedation requirements under topical or retrobulbar anesthesia. METHODS: In this prospective study, patients received either topical anesthesia (n=87) or retrobulbar block (n=104) and self-administered a mixture of midazolam (0.5 mg) and fentanyl (25 g) in increments using a patient controlled analgesia infuser to achieve sedation. At the end of surgery, patients rated their pain on a 10-point numerical rating scale and their comfort on a 5-point scale. The number of demands and deliveries were noted from the patient controlled analgesia infuser display. RESULTS: Pain scores were between 0 and 2 in 95.4% in the topical and in 94.2% in the retrobulbar group (p>0.05). Patient comfort was equal in both groups with 2.94 0.92 in the topical group and 2.92 0.99 in the retrobulbar group (p>0.05). Mean sedation requirements were similar in both groups: 26.4% of patients in the topical group and 19.2% in the retrobulbar group did not request any sedation (not significant, p>0.05). CONCLUSIONS: Sedation requirements were similar for cataract surgery under topical and retrobulbar anesthesia. (Eur J Ophthalmol 2004; 14: #-7).
RESUMEN
PURPOSE: Topical anesthesia is increasingly being used for cataract surgery. However, it is believed that topical anesthesia causes an increased risk of intraoperative complications from unrestricted eye movement and insufficient pain control and more need for sedation. It is difficult to compare pain and anxiety experienced by individual patients; therefore, the authors used the method of patient-controlled sedation to determine whether there is a difference in sedation requirements under topical or retrobulbar anesthesia. METHODS: In this prospective study, patients received either topical anesthesia (n=87) or retrobulbar block (n=104) and self-administered a mixture of midazolam (0.5 mg) and fentanyl (25 microg) in increments using a patient controlled analgesia infuser to achieve sedation. At the end of surgery, patients rated their pain on a 10-point numerical rating scale and their comfort on a 5-point scale. The number of demands and deliveries were noted from the patient controlled analgesia infuser display. RESULTS: Pain scores were between 0 and 2 in 95.4% in the topical and in 94.2% in the retrobulbar group (p>0.05). Patient comfort was equal in both groups with 2.94+/-0.92 in the topical group and 2.92+/-0.99 in the retrobulbar group (p>0.05). Mean sedation requirements were similar in both groups: 26.4% of patients in the topical group and 19.2% in the retrobulbar group did not request any sedation (not significant, p>0.05). CONCLUSIONS: Sedation requirements were similar for cataract surgery under topical and retrobulbar anesthesia.
Asunto(s)
Analgesia Controlada por el Paciente/métodos , Anestesia Local/métodos , Anestésicos Combinados/administración & dosificación , Sedación Consciente/métodos , Bloqueo Nervioso/métodos , Facoemulsificación/métodos , Anciano , Anestésicos Intravenosos/administración & dosificación , Anestésicos Locales/administración & dosificación , Femenino , Fentanilo/administración & dosificación , Humanos , Instilación de Medicamentos , Masculino , Midazolam/administración & dosificación , Dimensión del Dolor , Dolor Postoperatorio/diagnóstico , Satisfacción del Paciente , Estudios ProspectivosAsunto(s)
Proteínas del Tejido Nervioso/fisiología , Neurotransmisores/fisiología , Secuencia de Aminoácidos , Animales , Estimulantes del Sistema Nervioso Central/farmacología , Exones/genética , Conducta Alimentaria/fisiología , Regulación de la Expresión Génica , Carpa Dorada , Humanos , Área Hipotalámica Lateral/metabolismo , Ratones , Datos de Secuencia Molecular , Proteínas del Tejido Nervioso/genética , Neurotransmisores/genética , Núcleo Accumbens/metabolismo , Ratas , Recompensa , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Especificidad de la Especie , Estrés Fisiológico/fisiopatología , Área Tegmental Ventral/metabolismoRESUMEN
CART peptide is a neurotransmitter involved in various physiological processes including feeding, sensory processing, development, addiction, and stress. Substantial amounts of CART mRNA and CART peptide expression have been demonstrated in the hypothalamic periventricular area, the paraventricular nucleus of hypothalamus, the anterior lobe of the pituitary gland and the adrenal gland in addition to many other brain areas. This localization defines the HPA axis, responsible for the stress response. The aim of the present study was to assess the possible mediation of the CART peptides in the stress response by testing for changes in CART in adrenalectomized animals. Three groups of male Sprague-Dawley rats were used for the study: sham operated, adrenalectomized (ADX), and ADX+hormone replacement (corticosterone, 30 microg/ml in drinking water/5 days). All rats were perfused 7 days after the surgery, brains were removed and serial coronal sections were prepared. Immunohistochemistry was used to assess CART peptide expression in paraventricular and supraoptic cells. ADX lowered both the number and percentage of CART-positive cells compared to the sham-operated group, and hormone replacement partially restored the decrease in the CART cell numbers in ADX animals. There were no significant changes in the supraoptic nucleus. Our results suggest a role for CART peptides in the stress response.
Asunto(s)
Adrenalectomía , Proteínas del Tejido Nervioso/metabolismo , Núcleo Hipotalámico Paraventricular/metabolismo , Núcleo Supraóptico/metabolismo , Animales , Recuento de Células , Corticosterona/farmacología , Inmunohistoquímica , Masculino , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Núcleo Hipotalámico Paraventricular/citología , Ratas , Ratas Sprague-Dawley , Núcleo Supraóptico/citologíaRESUMEN
This article provides evidence of a new class of compounds, 1,3-diaryl-[1H]-pyrazole-4-acetamides, initially identified from their ability to increase glucose transport in an adipocyte and muscle cell line and ultimately demonstrating dramatic glucose lowering in ob/ob mice, a diabetic animal model. The lead compound, 1, possessed some behavioral-like effects which were removed by structural variation during the course of this investigation. Specifically, 11g (R1 = meta-CF(3), Ar2 = 4'biphenyl, R3 = diethylamide) illustrated the potency of this series with ED(50) values for glucose lowering in ob/ob mice of 3.0 mg/kg/day. Concomitant with its effect on glucose lowering, 11g also caused a 50% reduction in insulin levels consistent with an agent that increases whole body insulin sensitivity. 11g showed favorable pharmacokinetic data with acceptable absorption, negligible metabolism, and good duration of action. 11g demonstrated no appreciable adipogenic effect through PPAR gamma agonism, a characteristic of the thiazolidinediones (TZD), and so represents a potentially new class of agents for the treatment of diabetes.
Asunto(s)
Acetamidas/farmacología , Antiinflamatorios no Esteroideos/farmacología , Glucosa/metabolismo , Hipoglucemiantes/farmacología , Pirazoles/farmacología , Acetamidas/síntesis química , Acetamidas/química , Acetamidas/farmacocinética , Tejido Adiposo/citología , Animales , Antiinflamatorios no Esteroideos/síntesis química , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacocinética , Conducta Animal/efectos de los fármacos , Disponibilidad Biológica , Glucemia/análisis , Línea Celular , Diabetes Mellitus/sangre , Diabetes Mellitus/tratamiento farmacológico , Hipoglucemiantes/síntesis química , Hipoglucemiantes/química , Hipoglucemiantes/farmacocinética , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Músculo Esquelético/citología , Pirazoles/síntesis química , Pirazoles/química , Pirazoles/farmacocinética , Ratas , Ratas Sprague-Dawley , Relación Estructura-ActividadRESUMEN
Nicotine exerts its central actions by regulating cationic fluxes through nicotinic acetylcholine receptors (nAChRs). By this effect, the drug likely also modifies events occurring beyond the nAChR, including the regulation of nitric oxide (NO) synthesis. The present study was undertaken to assess the effects of acute and chronic nicotine administration (0.4 mg/kg, s.c.) on levels of NO(-)(2)+NO(-)(3), stable metabolites of NO, in brain regions of male and female rats. Nicotine increased levels of the metabolites, and therefore presumably of NO, with sex differences in the degree of stimulation, the brain regions affected, and the variance between the effects of acute and chronic administration. Prior inhibition of NO synthase eliminated the effect of nicotine in all regions studied. While nicotine appeared to increase NO indirectly via glutamate receptors in the cortex and hippocampus, this was not true of the corpus striatum, where blocking NMDA-type glutamate receptors with MK-801 had no effect. The findings support the view that NO is likely involved in some of the central effects of nicotine.
Asunto(s)
Cuerpo Estriado/efectos de los fármacos , Hipocampo/efectos de los fármacos , Nicotina/farmacología , Óxido Nítrico/metabolismo , Análisis de Varianza , Animales , Cuerpo Estriado/metabolismo , Maleato de Dizocilpina/farmacología , Inhibidores Enzimáticos/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Femenino , Estimulantes Ganglionares/administración & dosificación , Estimulantes Ganglionares/farmacología , Hipocampo/metabolismo , Indazoles/farmacología , Masculino , Nicotina/administración & dosificación , Nitratos/metabolismo , Nitritos/metabolismo , Nitroarginina/farmacología , Ratas , Ratas Sprague-Dawley , Caracteres Sexuales , Factores de TiempoAsunto(s)
Ingestión de Alimentos , Glucosa/metabolismo , Homeostasis , Neurotransmisores/fisiología , Fragmentos de Péptidos/fisiología , Animales , Dipeptidil Peptidasa 4/administración & dosificación , Dipeptidil Peptidasa 4/metabolismo , Ingestión de Alimentos/efectos de los fármacos , Ingestión de Alimentos/fisiología , Conducta Alimentaria , Glucagón , Péptido 1 Similar al Glucagón , Péptidos Similares al Glucagón , Homeostasis/efectos de los fármacos , Homeostasis/fisiología , Insulina/metabolismo , Mucosa Intestinal/metabolismo , Neurotransmisores/antagonistas & inhibidores , Neurotransmisores/farmacología , Nitrilos/farmacología , Fragmentos de Péptidos/antagonistas & inhibidores , Fragmentos de Péptidos/farmacología , Inhibidores de Proteasas/farmacología , Pirrolidinas/farmacología , RatasRESUMEN
The incretin glucagon-like peptide-1 (GLP-1)-(7---36) amide is an important factor in prandial glucose homeostasis. Findings that GLP-1 is rapidly inactivated led to the hypothesis that the target of GLP-1 is close to the site of release. To investigate whether the target tissue is located in the hepatoportal system, we administered GLP-1 with glucose into the portal vein of rats and compared this with peripheral GLP-1 administration (jugular vein) and studied the effects of blockers of the nervous system. Portal GLP-1 augmented the insulin response to a portal glucose bolus by 81% (P < 0.01) and markedly improved the glucose disposal rate (P < 0.05). Peripheral administration of GLP-1 produced a similar augmentation of the insulin response (88%) and of the glucose disposal rate. However, only the effect of portal GLP-1 on insulin secretion was blocked by the ganglionic blocker chlorisondamine. The data suggest that prandial beta-cell stimulation by GLP-1 is evoked via a neural reflex triggered in the hepatoportal system. Because absorbed nutrients and GLP-1 first appear in the portal system, this mechanism may constitute a major pathway of GLP-1 action during meals.
Asunto(s)
Glucemia/metabolismo , Insulina/metabolismo , Fragmentos de Péptidos/farmacología , Animales , Derivados de Atropina/administración & dosificación , Derivados de Atropina/farmacología , Glucemia/efectos de los fármacos , Clorisondamina/farmacología , Glucagón , Péptido 1 Similar al Glucagón , Péptidos Similares al Glucagón , Inyecciones Intravenosas , Insulina/sangre , Secreción de Insulina , Venas Yugulares , Cinética , Masculino , Parasimpatolíticos/administración & dosificación , Parasimpatolíticos/farmacología , Fragmentos de Péptidos/administración & dosificación , Vena Porta , Ratas , Ratas Sprague-Dawley , Factores de TiempoRESUMEN
We explored whether inhibition of the enzyme dipeptidyl peptidase IV (DPP IV) increases endogenous levels of glucagon-like peptide-1 (GLP-1) and improves glucose tolerance and insulin secretion in mice. Glucose (150 mg) was administered through a gastric gavage with or without the inhibitor of dipeptidyl peptidase IV, valine-pyrrolidide (100 micromol/kg), in high-fat fed glucose intolerant or control C57BL/6J mice. The increase in plasma GLP-1 after gastric glucose was potentiated by dipeptidyl peptidase IV inhibition (P<0.05). Valine-pyrrolidide also potentiated the plasma insulin response to gastric glucose and improved the glucose tolerance in both groups of mice (P<0.001). In contrast, valine-pyrrolidide did not affect glucose-stimulated insulin secretion from isolated islets. This suggests that valine-pyrrolidide improves insulin secretion and glucose tolerance through indirect action, probably through augmentation of levels of GLP-1 and other incretin hormones. Therefore, inhibition of dipeptidyl peptidase IV activity is feasible to exploit as a treatment for glucose intolerance and type 2 diabetes.
Asunto(s)
Glucemia/metabolismo , Dipeptidil Peptidasa 4/metabolismo , Glucosa/fisiología , Insulina/metabolismo , Animales , Peso Corporal , Femenino , Glucagón/sangre , Péptido 1 Similar al Glucagón , Prueba de Tolerancia a la Glucosa , Insulina/sangre , Secreción de Insulina , Ratones , Ratones Endogámicos C57BL , Fragmentos de Péptidos/sangre , Inhibidores de Proteasas/farmacología , Precursores de Proteínas/sangreRESUMEN
Because of the reported presence of both CART peptide and NOS activity in the same hypothalamic nuclei, their colocalization was examined. Eighteen percent of the neurons in the supraoptic nuclei, and 16% of the neurons in the paraventricular nucleus contained both CART immunoreactivity and NOS activity. Many other neurons in these regions stained for only one marker although they were often close by. Thus, CART peptides and NO may interact in these regions.
Asunto(s)
Ingestión de Alimentos/fisiología , Hipotálamo/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Neuronas/metabolismo , Óxido Nítrico Sintasa/metabolismo , Animales , Hipotálamo/citología , Masculino , Neuronas/citología , Ratas , Ratas Sprague-DawleyRESUMEN
In a water maze (WM), rats employ different and sexually dimorphic behavioral strategies to solve a place-learning task, a test of cognitive/propositional ability. Puberty is the last step in brain development and marks an important phase with regard to sexually dimorphic cognitive performance and behavior. The present study assessed possible sex differences in cognitive style before and after puberty in a WM place-learning task. Since nitric oxide (NO) is implicated in spatial learning and hippocampal function, and since brain NO(-)(2) + NO(-)(3) levels (stable metabolites of NO) display region-specific sex differences in rat brain, NO(-)(2) + NO(-)(3) levels were determined after behavioral testing. The sex-related style difference emerged very clearly but only in the adult rats, which suggests that the female behavioral strategy in the WM place-learning task requires the presence of female sex hormones at puberty. Although NO(-)(2) + NO(-)(3) levels were higher in the adult rats and males compared to prepubertal and female rats, respectively, no significant correlations emerged between brain NO and behavior. The fact that the behavioral sexually dimorphic cognitive-style effect observed here and in previous studies appears to emerge only after puberty suggests that awareness of such postpubertal sex differences may also be important in human educational and therapeutic contexts.
Asunto(s)
Cognición/fisiología , Caracteres Sexuales , Adaptación Psicológica/fisiología , Factores de Edad , Análisis de Varianza , Animales , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Femenino , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Aprendizaje por Laberinto/fisiología , Nitratos/metabolismo , Óxido Nítrico/metabolismo , Nitritos/metabolismo , Nitroarginina/farmacología , Ratas , Ratas Sprague-Dawley , Factores Sexuales , Natación/fisiologíaRESUMEN
AIMS/HYPOTHESIS: The potent incretin hormone glucagon-like peptide 1 (GLP-1) plays a pivotal role in prandial insulin secretion. In the circulation GLP-1 (7-36) amide is, however, rapidly (t(1/2):1-2 min) inactivated by the protease dipeptidyl peptidase IV (DPP-IV). We therefore investigated whether DPP-IV inhibition is a feasible approach to improve glucose homeostasis in insulin resistant, glucose intolerant fatty Zucker rats, a model of mild Type II (non-insulin-dependent) diabetes mellitus. METHODS: An oral glucose tolerance test was done in lean and obese male Zucker rats while plasma DPP-IV was inhibited by the specific and selective inhibitor NVP-DPP728 given orally. RESULTS: Inhibition of DPP-IV resulted in a significantly amplified early phase of the insulin response to an oral glucose load in obese fa/fa rats and restoration of glucose excursions to normal. In contrast, DPP-IV inhibition produced only minor effects in lean FA/? rats. Inactivation of GLP-1 (7-36) amide was completely prevented by DPP-IV inhibition suggesting that the effects of this compound on oral glucose tolerance are mediated by increased circulating concentrations of GLP-1 (7-36) amide. Reduced gastric emptying, as monitored by paracetamol appearance in the circulation after an oral bolus, did not appear to have contributed to the reduced glucose excursion. CONCLUSION/INTERPRETATION: It is concluded that NVP-DPP728 inhibits DPP-IV and improves insulin secretion and glucose tolerance, probably through augmentation of the effects of endogenous GLP-1. The improvement observed in prandial glucose homeostasis during DPP-IV inhibition suggests that inhibition of this enzyme is a promising treatment for Type II diabetes. [Diabetologia (1999) 42: 1324-1331]
Asunto(s)
Dipeptidil Peptidasa 4/metabolismo , Glucosa/fisiología , Nitrilos/farmacología , Obesidad/fisiopatología , Fragmentos de Péptidos/metabolismo , Pirrolidinas/farmacología , Animales , Dipeptidil Peptidasa 4/efectos de los fármacos , Glucagón , Péptido 1 Similar al Glucagón , Péptidos Similares al Glucagón , Prueba de Tolerancia a la Glucosa , Masculino , Obesidad/enzimología , Concentración Osmolar , Ratas , Ratas Zucker , Valores de ReferenciaRESUMEN
A series of substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones was synthesized from amino alcohols or amino thiols and keto acids. A pharmacological model based on the results obtained with these compounds led to the synthesis and evaluation of a series of isoxazoles and other monocyclic compounds. These were evaluated for their ability to enhance glucose utilization in cultured L6 myocytes. The in vivo hypoglycemic efficacy and potency of these compounds were evaluated in a model of type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus), the ob/ob mouse. 25a(2S) (SDZ PGU 693) was selected for further pharmacological studies.
Asunto(s)
Hipoglucemiantes/síntesis química , Oxazoles/síntesis química , Pirroles/síntesis química , Tiazoles/síntesis química , Animales , Línea Celular , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Evaluación Preclínica de Medicamentos , Glucosa/metabolismo , Hipoglucemiantes/química , Hipoglucemiantes/farmacología , Masculino , Ratones , Ratones Endogámicos C57BL , Músculos/citología , Oxazoles/química , Oxazoles/farmacología , Pirroles/química , Pirroles/farmacología , Ratas , Relación Estructura-Actividad , Tiazoles/química , Tiazoles/farmacologíaRESUMEN
We have recently reported an effect that shows a sexually dimorphic difference in cognitive style rather than ability. The preparation for potentially producing this proximal perceptual style effect is one where rats are first given 4-trial daily acquisition sessions for 12 days with the platform always in the same position, but sometimes visible (perceptual, "look-out" condition) and sometimes hidden (conceptual, "navigational" condition). On the first, probe trial of the 13th day, the platform's position is shifted to a point very close (proximal) to the rat's starting position, and made visible. The proximal perceptual style (PPS) effect has emerged sexually dimorphically in that only females swam straight to the newly positioned proximal platform. Other studies have shown that the PPS effect is eliminated (with females behaving like males) by nicotine and prepubertal ovariectomy, and does not occur in prepubertal females. Also, as no sex-related effects emerged during acquisition during these studies, the PPS effect appears to be a function of cognitive style rather than ability. The present study varied age, and, in an effort to economize on time, shortened acquisition to 6 days by having morning and afternoon sessions each day. To our surprise, this relatively subtle psychological manipulation eliminated the PPS effect, and also yielded some sex- and age-related effects during acquisition: A male advantage was observed and prepubertal rats had longer escape latencies; there was no significant interaction between sex and age.